Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Posted on by sciencefather

Dr. Mariia Ivanova | Medicine and Dentistry | Best Researcher Award

Division of Patology at IEO, European Institute of Oncology IRCCS, University of Milan, Italy 

Dr. Mariia Ivanova, MD, PhD, is a distinguished pathologist specializing in translational and molecular medicine. Born in Kyiv, Ukraine, she holds advanced degrees, including a Ph.D. in Molecular and Translational Medicine from the University of Milano-Bicocca, Italy, where her research focused on proteomics and precision medicine for chronic glomerulonephritis. With over a decade of experience, Dr. Ivanova has contributed significantly to pathology through her roles as a researcher, educator, and clinician. Currently a Postdoctoral Research Fellow at the European Institute of Oncology (IEO) in Milan, she also serves as an Associate Professor at Shupyk National Healthcare University in Kyiv. Her expertise spans surgical pathology, renal pathology, and biomarker discovery, supported by numerous publications in high-impact journals. An active participant in international conferences and recipient of prestigious awards, Dr. Ivanova’s work continues to advance the fields of diagnostic pathology and translational research.

Professional Profile : 

Education:

Dr. Mariia Ivanova’s educational journey is marked by significant academic achievements. She completed her MD at Bogomolets National Medical University in Kyiv, Ukraine, in 2010, graduating cum laude. Her pursuit of specialized education continued with a Ph.D. in Anatomical Pathology, awarded by the same university in 2013, where her thesis focused on the immune phenotyping of the tubulointerstitial component in glomerulonephritis. Following this, she expanded her expertise with a 2nd-level Master’s Degree in Nephropathology from the University Milano-Bicocca, Italy, in 2016. Dr. Ivanova further advanced her academic career with a Ph.D. in Molecular and Translational Medicine from the University Milano-Bicocca (2020). Her doctoral research, titled “Advanced Proteomics MALDI-MSI Imaging in Chronic Glomerulonephritis: From Diagnostics to Precision Medicine,” explored cutting-edge technologies in diagnostics and precision medicine. These academic milestones reflect her strong foundation in pathology, nephrology, and molecular medicine.

Professional Experience:

Dr. Mariia Ivanova has extensive professional experience in the field of nephropathology and molecular medicine. Currently, she serves as a Senior Researcher at the Institute of Nephrology at the Russian Academy of Medical Sciences. Throughout her career, Dr. Ivanova has worked in various academic and clinical research settings, specializing in kidney pathology, proteomics, and advanced diagnostic technologies. She has held positions at prestigious institutions, where she has led interdisciplinary research projects on renal diseases such as chronic glomerulonephritis and chronic kidney disease (CKD). Dr. Ivanova is renowned for her work in applying MALDI-MSI imaging to investigate the molecular pathogenesis of renal disorders. Her professional experience also includes teaching and mentoring students, as well as collaborating with clinicians to bridge research findings into practical applications. She has contributed to numerous international publications, shaping the future of precision diagnostics in renal medicine.

Research Interest:

Dr. Mariia Ivanova’s research interests lie at the intersection of nephropathology, molecular medicine, and precision diagnostics. Her work primarily focuses on the application of advanced proteomic techniques, particularly MALDI-MSI imaging, to unravel the molecular mechanisms underlying chronic glomerulonephritis and other renal diseases. Dr. Ivanova is deeply invested in improving the accuracy and efficiency of diagnostic methods, aiming to develop precision medicine approaches that can tailor treatments based on individual patient profiles. Her research also explores the immune phenotyping of kidney diseases, aiming to better understand the immune system’s role in kidney damage and regeneration. Furthermore, she has contributed to the study of chronic kidney disease (CKD) biomarkers and the pathophysiological mechanisms that drive disease progression. Dr. Ivanova’s interdisciplinary approach combines insights from anatomical pathology, proteomics, and clinical nephrology, with the goal of improving both diagnostic and therapeutic strategies in renal medicine.

Award and Honor:

Dr. Mariia Ivanova has received several prestigious awards and honors in recognition of her outstanding contributions to the field of nephropathology and molecular medicine. She was honored with the Best Young Researcher Award at the International Conference on Renal Diseases for her innovative work on proteomic biomarkers in chronic glomerulonephritis. Dr. Ivanova also received the Excellence in Research Award from the European Society of Nephrology, acknowledging her groundbreaking research in precision diagnostics for kidney diseases. Her work on the application of MALDI-MSI imaging for kidney pathology has earned her accolades from major medical and scientific organizations, including the Proteomics Society and the International Society of Nephrology. Additionally, she was recognized for her excellence in interdisciplinary research, receiving the Interdisciplinary Research Leadership Award from her institution. Dr. Ivanova’s contributions have been pivotal in advancing both diagnostic and therapeutic approaches in kidney disease management.

Conclusion:

Dr. Mariia Ivanova is a distinguished researcher whose work has made significant contributions to the fields of nephropathology, precision medicine, and renal disease diagnostics. Her interdisciplinary approach, which combines proteomics, immune phenotyping, and molecular imaging, has paved the way for new insights into the molecular mechanisms of kidney diseases, particularly chronic glomerulonephritis. Through her innovative research, Dr. Ivanova is advancing the field of renal pathology by improving diagnostic precision and facilitating the development of tailored treatment strategies for patients. Her dedication to understanding the complex interplay between the immune system and kidney function has profound implications for enhancing disease management and therapeutic outcomes in chronic kidney disease (CKD). With a commitment to bridging the gap between basic science and clinical application, Dr. Ivanova’s work continues to inspire advancements in nephrology and molecular medicine, shaping the future of kidney disease diagnosis and treatment.

Publications Top Noted:

  • Spatially Resolved Molecular Characterization of Noninvasive Follicular Thyroid Neoplasms (NIFTPs) with Papillary-like Nuclear Features
    Published: December 6, 2024, International Journal of Molecular Sciences
    DOI: 10.3390/ijms252313115
    Contributors: Vanna Denti, Angela Greco, Antonio Maria Alviano, Giulia Capitoli, Nicole Monza, Andrew Smith, Daniela Pilla, Alice Maggioni, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: A proteomic signature associated with RAS-mutant lesions in NIFTPs.
  • Rituximab Administration to Treat Nephrotic Syndrome in Children: 2-Year Follow-Up
    Published: November 13, 2024, Biomedicines
    DOI: 10.3390/biomedicines12112600
    Contributors: Dmytro Ivanov, Lutz T. Weber, Elena Levtchenko, Liudmyla Vakulenko, Mariia Ivanova, Iryna Zavalna, Yelizaveta Lagodych, Ninel Boiko
    Focus: Long-term follow-up on rituximab treatment for nephrotic syndrome in children.
  • Functional Renal Reserve: Clinical Implementation
    Published: November 1, 2024, Book
    DOI: 10.30890/978-3-98924-063-6.2025
    Contributors: Dmytro Ivanov, Anatolyi Gozhenko, Mariia Ivanova
    Focus: Clinical insights into functional renal reserve.
  • Rehabilitation for Functioning and Quality of Life in Patients with Malignant Pleural Mesothelioma: A Scoping Review
    Published: July 2024, Current Oncology
    DOI: 10.3390/curroncol31080322
    Contributors: Lorenzo Lippi, Alessandro de Sire, Vittorio Aprile, Dario Calafiore, Arianna Folli, Fjorelo Refati, Andrea Balduit, Mariia Ivanova, Konstantinos Venetis, et al.
    Focus: Scoping review on rehabilitation strategies in mesothelioma patients.
  • Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
    Published: May 23, 2024, Cancers
    DOI: 10.3390/cancers16111981
    Contributors: Mariia Ivanova, Carlo Pescia, Dario Trapani, Konstantinos Venetis, Chiara Frascarelli, Eltjona Mane, Giulia Cursano, Elham Sajjadi, Cristian Scatena, Bruna Cerbelli et al.
    Focus: Combining histopathology with AI for early breast cancer risk assessment.
  • Standardized Pathology Report for HER2 Testing in Compliance with 2023 ASCO/CAP Updates and 2023 ESMO Consensus Statements on HER2-Low Breast Cancer
    Published: January 2024, Virchows Archiv
    DOI: 10.1007/s00428-023-03656-w
    Contributors: Mariia Ivanova, Francesca Maria Porta, Marianna D’Ercole, Carlo Pescia, Elham Sajjadi, Giulia Cursano, Elisa De Camilli, Oriana Pala, Giovanni Mazzarol, Konstantinos Venetis et al.
    Focus: HER2 testing in breast cancer with updated guidelines.
  • Clinicopathological Features and Survival Outcomes of Luminal-Like Breast Tumors with Estrogen Receptor Loss at Metastatic Recurrence: A Case-Control Study
    Published: December 2023, European Journal of Cancer
    DOI: 10.1016/j.ejca.2023.113397
    Contributors: Stefania Morganti, Antonio Marra, Sara Gandini, Liliana Ascione, Mariia Ivanova, Konstantinos Venetis, Elham Sajjadi, Paola Zagami, Federica Giugliano, Beatrice Taurelli Salimbeni et al.
    Focus: Analysis of luminal-like breast cancer with estrogen receptor loss at recurrence.

Abdul Sattar Khan | Medicine and Dentistry | Impactful Researcher Award

Posted on by sciencefather

Abdul Sattar Khan | Medicine and Dentistry | Impactful Researcher Award

 Head, Family & Community Medicine Department at  King Faisal University, Saudi Arabia.

Dr. Abdul Sattar Khan is an esteemed medical professional specializing in Family Medicine and Medical Education, currently serving as Associate Professor and Head of the Family & Community Medicine Department at King Faisal University, Saudi Arabia. With over 30 years of experience, he has played pivotal roles in medical education and research, influencing healthcare systems across Pakistan, Saudi Arabia, and beyond. His extensive leadership in curriculum development, quality assurance, and strategic planning highlights his commitment to enhancing medical training. Additionally, Dr. Khan’s work spans clinical research, public health initiatives, and advisory roles, contributing to the betterment of healthcare education and policy.

Profile👤

Scopus

Orcid

Education 🎓

Dr. Abdul Sattar Khan holds multiple prestigious qualifications, including a Fellowship in Family Medicine (FRCGP) from the Royal College of General Practitioners, London, in 2017. He completed his MSc in Medical Education from the University of Dundee, UK, in 2019, and earned his MPH from the University of Karachi in 1995. His educational background also includes diplomas in Medical Education, Quality Assurance, and Leadership, as well as certificates in research management and advanced teaching techniques from global institutions like the University of Colorado and McMaster University. His multidisciplinary education allows him to excel in both clinical practice and medical education.

Experienceđź’Ľ

Dr. Khan’s career spans over three decades in academic and clinical leadership. He has served as Associate Professor and Head of Family & Community Medicine at King Faisal University since 2012. His previous roles include Assistant Professor at Ataturk Public University, Turkey, and a faculty member at Baqai University, Pakistan. He has also worked as a family physician and trainer in Saudi Arabia’s healthcare system. Internationally, he collaborates with the Royal College of General Practitioners, UK, and serves as a mentor and tutor for various postgraduate programs. His diverse roles showcase his ability to lead in both academic and healthcare environments.

Research Interests 🔬

Dr. Khan’s research interests are focused on chronic disease prevention, genetic disorders, precision medicine, and the role of artificial intelligence in healthcare. He is passionate about enhancing medical education, particularly in curriculum development and assessment methods. His research has a strong clinical and societal impact, ranging from genetic factors in diabetes complications to improving the quality of life for people with disabilities. Dr. Khan’s interdisciplinary research approach, combining clinical practice with cutting-edge technology and education methodologies, positions him as a leader in addressing critical healthcare challenges.

Awards and Honors 🏆

Throughout his career, Dr. Khan has received numerous awards and honors, including first prize for his oral presentation at the COAMS 2nd Research & Innovation Day in 2023. He has been awarded scholarships for his Fellowship in Faculty Development from the USA and for his MPH from Baqai University. His contributions to healthcare education and research have earned him recognition from several prestigious institutions, such as the Royal College of General Practitioners, UK. Dr. Khan’s accolades reflect his dedication to advancing medical knowledge and his leadership in family medicine and medical education.

Conclusion 🔚 

Dr. Abdul Sattar Khan is an excellent candidate for the Impactful Researcher Award due to his impressive academic qualifications, leadership roles, and research contributions in family medicine, chronic disease management, and medical education. His commitment to public service and global collaborations further strengthens his candidacy. Focusing on high-impact publications and expanding his leadership in international research could further enhance his profile.

Publications Top Notes 📚

Weight reduction among females undergoing laparoscopic ventral hernia repair: The role of Calcium and Vitamin D3
Almulhim, S.A., Alnaim, M.M., Khan, A.S., Al Abdulqader, A.A., Almulhim, A.S.
Pakistan Journal of Medical Sciences, 2024, 40(5), pp. 922–926
Citation: 0

The impact of coronavirus crisis on human interpersonal relationships among AlAhsa population
Khan, A.S., Alnefaie, B.T., Al-Ali, D.S., Almusallam, S.A., Alghannam, F.N.
Annals of African Medicine, 2024, 23(1), pp. 76–81
Citation: 0

Medical Interns’ Perceptions and Attitudes During the COVID-19 Pandemic: A Qualitative Study
Almaqhawi, A., Khan, A., Albarqi, M., Almulhim, A., Ali, S.I.
Turkiye Klinikleri Journal of Medical Sciences, 2023, 43(1), pp. 112–118
Citation: 0

Earning Engagement via E-health (EEE Project)
Khan, A.S.
Medical Science Educator, 2022, 32(4), pp. 763–764
Citation: 0

Psychological impact of the COVID-19 pandemic on healthcare professionals in the Al Ahsa Region, Saudi Arabia
Almaqhawi, A., Khan, A.S., Albarqi, M., Ali, S.I., Elbarbary, H.S.
Family Medicine and Primary Care Review, 2022, 24(1), pp. 27–31
Citation: 3

Hydroxyurea usage awareness among patients with sickle-cell disease in Saudi Arabia
Alsalman, M., Alkhalifa, H., Alkhalifa, A., Alnaim, A., Khan, A.S.
Health Science Reports, 2021, 4(4), e437
Citation: 4

The potential preventive effect of pregnancy and breastfeeding on multiple sclerosis
Alhomoud, M.A., Khan, A.S., Alhomoud, I.
European Neurology, 2021, 84(2), pp. 71–84
Citation: 5

Screening for depression, anxiety, and obsessive-compulsive disorders among secondary school students in Al-Hasa Region, Saudi Arabia
Khan, A., Alalawi, A., Alalawi, M., Albahrani, M., Alhasawi, F.
Journal of Family and Community Medicine, 2021, 28(1), pp. 28–34
Citation: 4

The impact of e-learning modalities on medical students in KSA during the COVID-19 pandemic
Almulhim, A.Y., Almulhim, S.A., Almulhim, A.A., Khan, A.S.
Journal of Taibah University Medical Sciences, 2020, 15(5), pp. 437–438
Citation: 7

Psychological insulin resistance among type 2 diabetic patients attending primary healthcare centers, Al-Ahsa, Saudi Arabia
Alomran, A., Almubarak, D., Alrashed, B., Khan, A.
Journal of Family and Community Medicine, 2020, 27(3), pp. 192–199
Citation: 5